{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:22:51Z","timestamp":1788967371053,"version":"build-2803163510"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Examination of major depressive disorder (MDD) treatment selection within a large health system allows for evaluation of adherence to guidelines and identification of trends affecting clinical care.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To characterize treatment selection patterns among those receiving Veterans Health Administration (VHA) outpatient care for MDD between fiscal year 2011 (FY11) and FY25.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study used VHA health records of veterans who received outpatient care for MDD. Outpatient procedure codes and prescription records were used to characterize annual proportions that received different forms of treatment. Veterans younger than 18 years or older than 109 years or who had a documented history of bipolar or schizophrenia spectrum illnesses were excluded.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The proportions of veterans receiving treatment with psychotherapy, specific medications, and medications by class were quantified annually. Psychotherapy engagement was defined based on at least 1 session within a given FY. Veterans were classified as having received a medication based on the presence of at least 1 prescription record within a given FY (excluding prescriptions of fewer than 7 days\u2019 duration).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 1\u202f583\u202f834 veterans (mean [SD] age, 51.4 [16.6] years; 1\u202f319\u202f301 [83.4%] male; 23\u202f287 [1.5%] Asian, 341\u202f846 [21.6%] Black or African American, and 1\u202f065\u202f904 [67.3%] White) received outpatient treatment between FY11 and FY25. Over time, decreasing proportions received psychotherapy (131\u202f614 of 182\u202f208 [72.2%] to 413\u202f129 of 661\u202f576 [62.4%]), antidepressants (ADs) (156\u202f307 [85.8%] to 512\u202f227 [77.4%]), and combination therapy (ie, psychotherapy with AD: 117\u202f936 [64.7%] to 331\u202f190 [50.1%]), while increasing proportions received psychotherapy without AD (13\u202f678 [7.5%] to 81\u202f939 [12.4%]), AD without psychotherapy (38\u202f371 [21.1%] to 181\u202f037 [27.4%]), and neither psychotherapy nor AD (12\u202f223 [6.7%] to 67\u202f410 [10.2%]). There was decreasing use of selective serotonin reuptake inhibitors (SSRIs) (58.1% to 43.8%) and benzodiazepines (24.7% to 5.4%) and increasing use of serotonin-norepinephrine reuptake inhibitors (SNRIs) (15.6% to 22.3%). Demographic differences in treatment and medication-specific trends were also observed.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of 1\u202f582\u202f834 veterans with MDD, most received recommended treatment, but there was an increasing trend in the proportion who did not (up to 10.2% in 2025). The findings require further investigation into potential undertreatment of VHA outpatients with MDD and underscore the need to examine mental health service availability and other factors that influence treatment selection decisions.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.28853","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:30:30Z","timestamp":1786635030000},"page":"e2628853","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Selection for Major Depressive Disorder in Veterans Health Administration Outpatients"],"prefix":"10.1001","volume":"9","author":[{"given":"Mihaela","family":"Aslan","sequence":"first","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Tylee","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Chen","sequence":"additional","affiliation":[{"name":"Geriatric Research, Education and Clinical Center (GRECC) VISN10 and Psychiatry Service, VA Northeast Ohio Healthcare System, Cleveland"},{"name":"Geriatric Psychiatry Section, Department of Psychiatry, Case Western Reserve University School of Medicine, University Hospitals Health System, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Li","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Mutalik","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Biomedical Informatics & Data Science, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayuan","family":"Huang","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Polimanti","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Biomedical Informatics & Data Science, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoheng","family":"Wang","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut"},{"name":"Department of Biomedical Informatics & Data Science, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaia","family":"Mohamed","sequence":"additional","affiliation":[{"name":"VA Cooperative Studies Program Clinical Epidemiology Research Center (CSP-CERC), VA Connecticut Healthcare System, West Haven"},{"name":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"6","key":"zoi260785r1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018).","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"10128","key":"zoi260785r7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"zoi260785r8","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2009.60.11.1439","author":"Gaynes","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"8","key":"zoi260785r9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4088\/JCP.v66n0803","article-title":"Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.","volume":"66","author":"Thase","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"zoi260785r10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.","volume":"354","author":"Rush","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi260785r11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D Randomized Clinical Trial.","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"zoi260785r12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/MLR.0b013e318178eb08","article-title":"The prevalence and predictors of mental health treatment services in a national sample of depressed veterans.","volume":"46","author":"Chermack","year":"2008","journal-title":"Med Care"},{"issue":"36","key":"zoi260785r13","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.2174\/138161212803523653","article-title":"Choice of treatment with antidepressants: influencing factors.","volume":"18","author":"Himmerich","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"5","key":"zoi260785r14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.18553\/jmcp.2015.21.5.424","article-title":"Predictors of start of different antidepressants in patient charts among patients with depression.","volume":"21","author":"Kim","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"zoi260785r15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ps.201300057","article-title":"Racial and ethnic differences in receipt of antidepressants and psychotherapy by veterans with chronic depression.","volume":"65","author":"Qui\u00f1ones","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"1","key":"zoi260785r16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jphs.12122","article-title":"Receipt of pharmacotherapy and psychotherapy among a nationally representative US sample of privately insured adults with depression: associations with insurance plan arrangements and provider specialty.","volume":"7","author":"Soria-Saucedo","year":"2016","journal-title":"J Pharm Health Serv Res"},{"issue":"7","key":"zoi260785r17","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1176\/appi.ajp.161.7.1285","article-title":"Which factors influence psychiatrists\u2019 selection of antidepressants?","volume":"161","author":"Zimmerman","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"10","key":"zoi260785r18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pds.1985","article-title":"Predictors of alternative antidepressant agent initiation among US veterans diagnosed with depression.","volume":"19","author":"Kim","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"zoi260785r19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4088\/JCP.08m04450","article-title":"Use of antipsychotics in the treatment of major depressive disorder in the US Department of Veterans Affairs.","volume":"70","author":"Mohamed","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi260785r20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/JCP.0b013e318217b4c4","article-title":"Benzodiazepines and adequacy of initial antidepressant treatment for depression.","volume":"31","author":"Pfeiffer","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"zoi260785r21","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2829","article-title":"Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system.","volume":"37","author":"Tsai","year":"2022","journal-title":"Hum Psychopharmacol"},{"key":"zoi260785r22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jad.2022.03.058","article-title":"Characteristics and current standard of care among veterans with major depressive disorder in the United States: a real-world data analysis.","volume":"307","author":"Zhao","year":"2022","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi260785r23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi260785r24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models.","volume":"73","year":"1986","journal-title":"Biometrika"},{"issue":"8","key":"zoi260785r26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s11606-017-4297-2","article-title":"Treatment initiation for new episodes of depression in primary care settings.","volume":"33","author":"Waitzfelder","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi260785r27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.18553\/jmcp.2023.29.6.614","article-title":"Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States.","volume":"29","author":"Pizzicato","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"zoi260785r29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/JGP.0b013e3181ff6655","article-title":"Depression treatment in older adult veterans.","volume":"20","author":"Burnett-Zeigler","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"zoi260785r30","doi-asserted-by":"publisher","journal-title":"BMC Geriatr","DOI":"10.1186\/s12877-019-1327-4"},{"issue":"12","key":"zoi260785r31","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/pme.12177","article-title":"Sex differences in the medical care of VA patients with chronic non-cancer pain.","volume":"14","author":"Weimer","year":"2013","journal-title":"Pain Med"},{"key":"zoi260785r32","doi-asserted-by":"publisher","first-page":"i5309","DOI":"10.1136\/bmj.i5309","article-title":"Revisiting the drug interaction between tamoxifen and SSRI antidepressants.","volume":"354","author":"Juurlink","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"zoi260785r33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/2327-6924.12137","article-title":"The efficacy and tolerability of SSRI\/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.","volume":"27","author":"Handley","year":"2015","journal-title":"J Am Assoc Nurse Pract"},{"issue":"3","key":"zoi260785r34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1017\/S0033291716002579","article-title":"Age-related variability in the presentation of symptoms of major depressive disorder.","volume":"47","author":"Schaakxs","year":"2017","journal-title":"Psychol Med"},{"issue":"2","key":"zoi260785r35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi260785r36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1176\/appi.ps.202100617","article-title":"Long-term benzodiazepine use and discontinuation among patients in the US Veterans Health Administration.","volume":"73","author":"Timko","year":"2022","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi260785r37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1176\/appi.ajp.161.4.654","article-title":"Benzodiazepine use among depressed patients treated in mental health settings.","volume":"161","author":"Valenstein","year":"2004","journal-title":"Am J Psychiatry"},{"key":"zoi260785r38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse.","volume":"187","author":"Cook","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"zoi260785r39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.genhosppsych.2023.09.002","article-title":"Race, economic status, and disparities in the receipt of benzodiazepine prescriptions in a large primary care sample.","volume":"85","author":"Dore","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi260785r2","unstructured":"US Department of Veterans Affairs. VA research on mental health. Accessed January 23, 2023. https:\/\/www.research.va.gov\/topics\/mental_health.cfm"},{"key":"zoi260785r3","unstructured":"US Department of Veterans Affairs. About VHA. Accessed September 29, 2024. https:\/\/www.va.gov\/health\/aboutvha.asp"},{"key":"zoi260785r4","unstructured":"McQuaid? JR, Lin? EH, Barber? JP, . APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. 2019. Accessed July 6, 2026. https:\/\/www.apa.org\/depression-guideline"},{"key":"zoi260785r5","unstructured":"The Management of Major Depressive Disorder Work Group. VA\/DoD clinical practice guideline for the management of major depressive disorder (MDD) (2022). Accessed July 6, 2026. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/mdd"},{"key":"zoi260785r6","unstructured":"VA PBM Academic Detailing Service. Depression: clinical pearls for depression management. Accessed September 29, 2024. https:\/\/www.pbm.va.gov\/PBM\/AcademicDetailingService\/Documents\/508\/IB10-1494DEP-ProviderDepressioninPrimaryCareQRG_508Ready.pdf"},{"key":"zoi260785r25","unstructured":"Blue Review. Documentation and coding series: major depressive disorder. May 2021. Accessed April 13, 2026. https:\/\/www.bcbsilcommunications.com\/newsletters\/br\/2021\/may\/documentation_and_coding.html"},{"key":"zoi260785r28","unstructured":"Terlizzi? EP, Zablotsky? B. Mental health treatment among adults: United States, 2019. NCHS Data Brief No. 380. September 2020. Accessed September 11, 2024. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db380.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852733\/aslan_2026_oi_260785_1788368796.26616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:00:44Z","timestamp":1788966044000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.28853","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}